Mereo BioPharma Income Statement (2020-2025) | MREO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	-121.23B	-0.00B	-0.00B	-0.00B	-0.00B		0.01B		0.00B					-0.00B	0.00B
Gross Profit						-0.00B	0.01B	-0.00B	0.00B						0.00B
Operating items
Research & Development						0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.00B
Selling, General & Administrative						0.01B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Other Operating Expenses												-0.01B				0.00B
Operating Expenses						0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B
Operating Income						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B
EBIT						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B
Non-operating items
Non Operating Investment Income						0.00B	-0.00B		-0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B
Interest & Investment Income						0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non Operating Income						-0.00B			-0.00B
Non Operating Income						-0.00B			-0.00B
Net income details
EBT						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Tax Provisions									-0.00B
Profit After Tax						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Income from Continuing Operations						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Consolidated Net Income						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Income towards Parent Company						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Net Income towards Common Stockholders						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B
Additional items
EPS (Basic)						-0.02		-0.01	-0.01	-0.01	-0.02	-0.02	-0.01	-0.02	-0.02	-0.01
EPS (Weighted Average and Diluted)						-0.02		-0.01	-0.01	-0.01	-0.02	-0.02	-0.01	-0.02	-0.02	-0.01
Shares Outstanding (Weighted Average)				26.96		0.62B		0.68B	0.66B	0.70B	0.77B	0.77B	0.74B	0.78B	0.80B	0.80B
Shares Outstanding (Diluted Average)						0.62B		0.68B	0.66B	0.70B	0.77B	0.77B	0.74B	0.78B	0.80B	0.80B
EBITDA						-0.01B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B
Interest Expenses						0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Shares Outstanding				0.79B		0.62B		0.70B	0.70B	0.70B	0.77B	0.77B	0.78B	0.80B	0.80B	0.80B
Tax Rate									5.52

Research Tools

Mereo BioPharma Income Statement (2020-2025) | MREO

Create an account

Sign In

Reset Password